Molecular Endocrinology, Vol 8, 1484-1493, Copyright © 1994 by Endocrine Society

ARTICLES

Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter

DA Towler, SJ Rutledge and GA Rodan
Department of Bone Biology and Osteoporosis Research, Merck/Merck Research Laboratories, West Point, Pennsylvania 19486.

We recently defined an element (ACTAATTGG) within the rat osteocalcin (OC) promoter at -84 to -92 which provides approximately 70% of basal promoter activity in osteoblastic cell lines and binds a specific nuclear factor found in OC-producing ROS 17/2.8 osteosarcoma cells. Since this element closely resembles the recently described Msx-1 (Hox 7.1) homeodomain DNA binding cognate, we examined rodent osteoblastic cells lines for expression of Msx homeodomain-encoding messages. We have found and cloned a cDNA for rat Msx-2 (Hox 8.1) from a ROS 17/2.8 library and detect high levels of expression in various osteoblastic cell lines (ROS 17/2.8, RCT3, RCT1) as well as in culture passage 3 neonatal rat calvarial osteoblastic cells. Little to no expression was detected in phenotypically immature MC3T3E1 osteoblastic cells or in a variety of nonosteoblastic (ROS 25/1, C2C12, TRAB 11) mesenchymal cell lines. Dexamethasone (DEX) down-regulates Msx-2 message levels in both RCT3 and ROS 17/2.8 cells. Recombinant rat Msx-2 homeodomain expressed in Escherichia coli as a glutathione-S-transferase fusion protein binds to the rat OC promoter region -74 to -100 as determined by gel shift analysis. Recognition is dependent upon the intact ACTAATTGG motif at - 84 to -92. In transient cotransfection assays using MC3T3E1 cells (which expresses very little or no endogenous Msx-2), Msx-2 suppresses the rat OC promoter 2- to 3-fold via the Msx-2 binding motif at -84 to - 92. However, in ROS 17/2.8 cells, where a high level of endogenous Msx- 2 mRNA is present, expression of exogenous Msx-2 does not suppress the rat OC promoter; surprisingly, Msx-2 further augments basal promoter activity by approximately 50-70%, again dependent upon the ACTAATTGG motif at -84 to -92. These data directly demonstrate that the Msx-2 homeodomain binds the rat OC promoter and that Msx-2 can act as a sequence-specific transcriptional regulator of the rat OC promoter in cultured osteoblastic cell lines. This activity is dependent upon the specific osteoblastic cellular context, similar to previous observations in nonosseous systems with other homeodomain transcription factors. These data suggest that Msx-2 may play a role in the transcriptional regulation of the osteoblast phenotype during development in the morphogenetic fields where it is expressed.

This article has been cited by other articles:

				S.-L. Cheng, J.-S. Shao, J. Cai, O. L. Sierra, and D. A. Towler Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling J. Biol. Chem., July 18, 2008; 283(29): 20505 - 20522. [Abstract] [Full Text] [PDF]

				M.-H. Lee, Y.-J. Kim, W.-J. Yoon, J.-I. Kim, B.-G. Kim, Y.-S. Hwang, J. M. Wozney, X.-Z. Chi, S.-C. Bae, K.-Y. Choi, et al. Dlx5 Specifically Regulates Runx2 Type II Expression by Binding to Homeodomain-response Elements in the Runx2 Distal Promoter J. Biol. Chem., October 21, 2005; 280(42): 35579 - 35587. [Abstract] [Full Text] [PDF]

				M. Q. Hassan, A. Javed, M. I. Morasso, J. Karlin, M. Montecino, A. J. van Wijnen, G. S. Stein, J. L. Stein, and J. B. Lian Dlx3 Transcriptional Regulation of Osteoblast Differentiation: Temporal Recruitment of Msx2, Dlx3, and Dlx5 Homeodomain Proteins to Chromatin of the Osteocalcin Gene Mol. Cell. Biol., October 15, 2004; 24(20): 9248 - 9261. [Abstract] [Full Text] [PDF]

				S. Chen, A. Unterbrink, S. Kadapakkam, J. Dong, T. T. Gu, J. Dickson, H.-H. Chuang, and M. MacDougall Regulation of the Cell Type-specific Dentin Sialophosphoprotein Gene Expression in Mouse Odontoblasts by a Novel Transcription Repressor and an Activator CCAAT-binding Factor J. Biol. Chem., October 1, 2004; 279(40): 42182 - 42191. [Abstract] [Full Text] [PDF]

				F. Ichida, R. Nishimura, K. Hata, T. Matsubara, F. Ikeda, K. Hisada, H. Yatani, X. Cao, T. Komori, A. Yamaguchi, et al. Reciprocal Roles of Msx2 in Regulation of Osteoblast and Adipocyte Differentiation J. Biol. Chem., August 6, 2004; 279(32): 34015 - 34022. [Abstract] [Full Text] [PDF]

				T. Yoshizawa, F. Takizawa, F. Iizawa, O. Ishibashi, H. Kawashima, A. Matsuda, N. Endo, and H. Kawashima Homeobox Protein Msx2 Acts as a Molecular Defense Mechanism for Preventing Ossification in Ligament Fibroblasts Mol. Cell. Biol., April 15, 2004; 24(8): 3460 - 3472. [Abstract] [Full Text] [PDF]

				D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337. [Abstract] [Full Text] [PDF]

				M. Bidder, J.-S. Shao, N. Charlton-Kachigian, A. P. Loewy, C. F. Semenkovich, and D. A. Towler Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells Is Controlled by Glucose-regulated Upstream Stimulatory Factor and Activator Protein-1 Activities J. Biol. Chem., November 8, 2002; 277(46): 44485 - 44496. [Abstract] [Full Text] [PDF]

				D. M. Willis, A. P. Loewy, N. Charlton-Kachigian, J.-S. Shao, D. M. Ornitz, and D. A. Towler Regulation of Osteocalcin Gene Expression by a Novel Ku Antigen Transcription Factor Complex J. Biol. Chem., September 27, 2002; 277(40): 37280 - 37291. [Abstract] [Full Text] [PDF]

				K. Sooy and M. B. Demay Transcriptional Repression of the Rat Osteocalcin Gene by {delta}EF1 Endocrinology, September 1, 2002; 143(9): 3370 - 3375. [Abstract] [Full Text] [PDF]

				D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF]

				S. Matsubara, Y. Wada, T. A. Gardner, M. Egawa, M.-S. Park, C.-L. Hsieh, H. E. Zhau, C. Kao, S. Kamidono, J. Y. Gillenwater, et al. A Conditional Replication-competent Adenoviral Vector, Ad-OC-E1a, to Cotarget Prostate Cancer and Bone Stroma in an Experimental Model of Androgen-independent Prostate Cancer Bone Metastasis Cancer Res., August 1, 2001; 61(16): 6012 - 6019. [Abstract] [Full Text] [PDF]

				C. Blin-Wakkach, F. Lezot, S. Ghoul-Mazgar, D. Hotton, S. Monteiro, C. Teillaud, L. Pibouin, S. Orestes-Cardoso, P. Papagerakis, M. Macdougall, et al. Endogenous Msx1 antisense transcript: In vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals PNAS, May 30, 2001; (2001) 131497098. [Abstract] [Full Text] [PDF]

				A. Javed, G. L. Barnes, B. O. Jasanya, J. L. Stein, L. Gerstenfeld, J. B. Lian, and G. S. Stein runt Homology Domain Transcription Factors (Runx, Cbfa, and AML) Mediate Repression of the Bone Sialoprotein Promoter: Evidence for Promoter Context-Dependent Activity of Cbfa Proteins Mol. Cell. Biol., April 15, 2001; 21(8): 2891 - 2905. [Abstract] [Full Text]

				F. Lecanda, P. M. Warlow, S. Sheikh, F. Furlan, T. H. Steinberg, and R. Civitelli Connexin43 Deficiency Causes Delayed Ossification, Craniofacial Abnormalities, and Osteoblast Dysfunction J. Cell Biol., November 13, 2000; 151(4): 931 - 944. [Abstract] [Full Text] [PDF]

				A. Yamaguchi, T. Komori, and T. Suda Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1 Endocr. Rev., August 1, 2000; 21(4): 393 - 411. [Abstract] [Full Text] [PDF]

				M. D. Benson, J. L. Bargeon, G. Xiao, P. E. Thomas, A. Kim, Y. Cui, and R. T. Franceschi Identification of a Homeodomain Binding Element in the Bone Sialoprotein Gene Promoter That Is Required for Its Osteoblast-selective Expression J. Biol. Chem., April 28, 2000; 275(18): 13907 - 13917. [Abstract] [Full Text] [PDF]

				M. F. van Gurp, J. Pratap, M. Luong, A. Javed, H. Hoffmann, A. Giordano, J. L. Stein, E. J. Neufeld, J. B. Lian, G. S. Stein, et al. The CCAAT Displacement Protein/cut Homeodomain Protein Represses Osteocalcin Gene Transcription and Forms Complexes with the Retinoblastoma Protein-related Protein p107 and Cyclin A Cancer Res., December 1, 1999; 59(23): 5980 - 5988. [Abstract] [Full Text] [PDF]

				A. Javed, S. Gutierrez, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian Multiple Cbfa/AML Sites in the Rat Osteocalcin Promoter Are Required for Basal and Vitamin D-Responsive Transcription and Contribute to Chromatin Organization Mol. Cell. Biol., November 1, 1999; 19(11): 7491 - 7500. [Abstract] [Full Text] [PDF]

				H. Harada, S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori, and M. Nakatsuka Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation J. Biol. Chem., March 12, 1999; 274(11): 6972 - 6978. [Abstract] [Full Text] [PDF]

				R.T. Franceschi The Developmental Control of Osteoblast-Specific Gene Expression: Role of Specific Transcription Factors and the Extracellular Matrix Environment Critical Reviews in Oral Biology & Medicine, January 1, 1999; 10(1): 40 - 57. [Abstract] [Full Text] [PDF]

				D. Inoue, M. Reid, L. Lum, J. Kratzschmar, G. Weskamp, Y. M. Myung, R. Baron, and C. P. Blobel Cloning and Initial Characterization of Mouse Meltrin beta  and Analysis of the Expression of Four MetalloproteaseDisintegrins in Bone Cells J. Biol. Chem., February 13, 1998; 273(7): 4180 - 4187. [Abstract] [Full Text] [PDF]

				H. Kim, D. Rice, P. Kettunen, and I Thesleff FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development Development, January 4, 1998; 125(7): 1241 - 1251. [Abstract] [PDF]

				E. P. Newberry, J. M. Boudreaux, and D. A. Towler Stimulus-selective Inhibition of Rat Osteocalcin Promoter Induction and Protein-DNA Interactions by the Homeodomain Repressor Msx2 J. Biol. Chem., November 21, 1997; 272(47): 29607 - 29613. [Abstract] [Full Text] [PDF]

				V. D. Sarapura, H. L. Strouth, D. F. Gordon, W. M. Wood, and E. C. Ridgway Msx1 Is Present in Thyrotropic Cells and Binds to a Consensus Site on the Glycoprotein Hormone {alpha}-Subunit Promoter Mol. Endocrinol., November 1, 1997; 11(12): 1782 - 1794. [Abstract] [Full Text]

				H. M. Ryoo, H. M. Hoffmann, T. Beumer, B. Frenkel, D. A. Towler, G. S. Stein, J. L. Stein, A. J. van Wijnen, and J. B. Lian Stage-Specific Expression of Dlx-5 during Osteoblast Differentiation: Involvement in Regulation of Osteocalcin Gene Expression Mol. Endocrinol., October 1, 1997; 11(11): 1681 - 1694. [Abstract] [Full Text]

				L. Rifas, D. A. Towler, and L. V. Avioli Gestational exposure to ethanol suppresses msx2 expression in developing mouse embryos PNAS, July 8, 1997; 94(14): 7549 - 7554. [Abstract] [Full Text] [PDF]

				J. B. Lian, V. Shalhoub, F. Aslam, B. Frenkel, J. Green, M. Hamrah, G. S. Stein, and J. L. Stein Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression Endocrinology, May 1, 1997; 138(5): 2117 - 2127. [Abstract] [Full Text] [PDF]

				M. Dodig, MarkS. Kronenberg, A. Bedalov, BarbaraE. Kream, G. Gronowicz, StephenH. Clark, K. Mack, Y.-H. Liu, R. Maxon, Z. Pan, et al. Identification of a TAAT-containing Motif Required for High Level Expression of the COL1A1 Promoter in Differentiated Osteoblasts of Transgenic Mice J. Biol. Chem., July 5, 1996; 271(27): 16422 - 16429. [Abstract] [Full Text] [PDF]

				J. M. Boudreaux and D. A. Towler Synergistic Induction of Osteocalcin Gene Expression J. Biol. Chem., March 29, 1996; 271(13): 7508 - 7515. [Abstract] [Full Text] [PDF]

				C. Blin-Wakkach, F. Lezot, S. Ghoul-Mazgar, D. Hotton, S. Monteiro, C. Teillaud, L. Pibouin, S. Orestes-Cardoso, P. Papagerakis, M. Macdougall, et al. Endogenous Msx1 antisense transcript: In vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals PNAS, June 19, 2001; 98(13): 7336 - 7341. [Abstract] [Full Text] [PDF]

				Y.-W. Zhang, N. Yasui, K. Ito, G. Huang, M. Fujii, J.-i. Hanai, H. Nogami, T. Ochi, K. Miyazono, and Y. Ito A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia PNAS, September 12, 2000; 97(19): 10549 - 10554. [Abstract] [Full Text] [PDF]